GP-Act III Acquisition EBITDA Growth & History (GPAT)

GP-Act III Acquisition's calculated EBITDA was −$551,918 for fiscal 2025.

View full GP-Act III Acquisition company overview

GP-Act III Acquisition annual ebitda history

GP-Act III Acquisition annual ebitda

Fiscal yearPeriod endedEBITDAChangeGrowth
20252025-12-31−$551,918$13,055—
20242024-12-31−$564,973−$550,932—
20232023-12-31−$14,041$16,803—
20222022-12-31−$30,844——

GP-Act III Acquisition ebitda trends

Between the periods ended 2022-12-31 and 2025-12-31, GP-Act III Acquisition's ebitda decreased from −$30,844 to −$551,918, a change of −$521,074. The latest reported quarter, Q2 2026, shows −$1.5M.

About the metric

What EBITDA means

EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.

Calculation and source

How TickerStat calculates EBITDA

TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review GP-Act III Acquisition source filings ↗

Community posts

It’s quiet here.

No posts about GPAT yet. Start the conversation.

Write the first post